Symptoms of anxiety in women
Pro Research Analysisby 
Searched over 200M research papers
Symptoms of Anxiety in Women
Anxiety Symptoms in Women with Polycystic Ovary Syndrome (PCOS)
Women with Polycystic Ovary Syndrome (PCOS) exhibit a significantly higher prevalence of anxiety symptoms compared to those without the condition. Studies have shown that generalized anxiety symptoms are notably more common in women with PCOS, with a prevalence rate of 20.4% compared to 3.9% in control groups1. Additionally, women with PCOS are at increased odds of experiencing moderate to severe anxiety symptoms, independent of obesity and other factors4 7. This heightened anxiety may be linked to specific PCOS-related issues such as hirsutism, obesity, and infertility, although further research is needed to confirm these associations1 4.
Anxiety During Menopause
The menopausal transition is another critical period where women are more likely to experience anxiety symptoms. Research indicates that the prevalence of anxiety increases from 3.1% in premenopausal women to 7.4% in postmenopausal women2. This increase is attributed to various factors, including poor health status, sleep disturbances, and hormonal changes. Women in the perimenopausal and postmenopausal stages are at a higher risk of anxiety compared to their premenopausal counterparts2 6.
Anxiety in the Perinatal Period
The perinatal period, encompassing pregnancy and the postpartum phase, is also associated with elevated anxiety levels. During the COVID-19 pandemic, the prevalence of antenatal anxiety was found to be as high as 40%, with postnatal anxiety also significantly elevated3. Women experiencing medically complicated pregnancies report higher levels of anxiety compared to those with uncomplicated pregnancies5. Factors such as a history of depression, severe nausea, and negative life events contribute to increased anxiety during pregnancy9.
Postpartum Anxiety Disorders
Postpartum anxiety disorders, including generalized anxiety disorder (GAD), panic disorder (PD), obsessive-compulsive disorder (OCD), and posttraumatic stress disorder (PTSD), are common and can have significant consequences for both mothers and their children. Women often experience a range of cognitive, affective, and somatic symptoms, such as loss, frustration, guilt, and physical tension8. These disorders can negatively impact parenting and child development, highlighting the need for effective screening and intervention strategies8.
Conclusion
Anxiety symptoms in women can manifest during various life stages, including those with PCOS, during menopause, and throughout the perinatal period. The prevalence and severity of these symptoms are influenced by a range of factors, including hormonal changes, health status, and life events. Effective screening and tailored interventions are essential to address and mitigate the impact of anxiety on women's health and well-being.
Sources and full results
Most relevant research papers on this topic
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis.
Women with polycystic ovary syndrome (PCOS) have a significantly higher prevalence of anxiety symptoms, emphasizing the need for screening and follow-up evaluation and treatment.
Meta-Analysis
Highly CitedSymptoms of anxiety and depression among Chinese women transitioning through menopause: findings from a prospective community-based cohort study.
Symptoms of depression are more prevalent than symptoms of anxiety in Chinese women transitioning through menopause, with risk factors including poor health, sleep issues, and night sweats.
Observational StudyAnxiety and depressive symptoms of women in the perinatal period during the COVID-19 pandemic: A systematic review and meta-analysis
During the COVID-19 pandemic, perinatal anxiety and depressive symptoms were more prevalent than usual, emphasizing the need for increased support and mitigation strategies for pregnant women and mothers.
Meta-Analysis
Rigorous JournalHighly CitedHigh prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis
Women with polycystic ovary syndrome (PCOS) have significantly increased odds of moderate and severe depressive and anxiety symptoms, regardless of obesity, and these symptoms are weakly associated with age, BMI, elevated testosterone, hirsutism, and insulin resistance.
Meta-AnalysisRigorous JournalHighly CitedAnxiety among women experiencing medically complicated pregnancy: A systematic review and meta-analysis.
Women experiencing a medically complex pregnancy report higher levels of anxiety symptoms compared to those experiencing a medically uncomplicated pregnancy.
Meta-AnalysisVariation in symptoms of depression and anxiety in midlife women by menopausal status.
Menopausal status is associated with increased risk of depression and anxiety, with perimenopause being associated with increased depression symptoms and postmenopause with increased anxiety symptoms.
Observational StudyHighly CitedThe prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis
Women with PCOS have a high prevalence of anxiety and depression, with mild symptoms being more common, and obesity may increase the risk of depression.
Meta-AnalysisWomen’s experiences with postpartum anxiety disorders: a narrative literature review
Postpartum anxiety disorders may negatively impact parenting and child development, but more robust longitudinal studies are needed to develop therapeutic preventative interventions.
Systematic ReviewRigorous JournalDepression and anxiety during pregnancy: The influence of maternal characteristics
Depression and anxiety are common in both early and late pregnancy, with factors like low education, multiparity, and history of depression increasing the risk of depressive symptoms.
Observational StudyHighly CitedNon-pharmacological interventions to reduce the symptoms of mild to moderate anxiety in pregnant women. A systematic review and narrative synthesis of women’s views on the acceptability of and satisfaction with interventions
Pregnant women find non-pharmacological interventions to reduce anxiety overwhelmingly acceptable and satisfying, benefiting from peer support and individual discussions.
Systematic ReviewRigorous Journal